Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enovid for Asymptomatic or Mild COVID-19
NCT05012319Phase 3Unknown
- Sponsor
- Salmaniya Medical Complex
- Start
- Aug 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of norethynodrel + mestranol in coronavirus disease 2019 (COVID-19), sponsored by Salmaniya Medical Complex. Status: unknown.
02
Drugs
norethynodrel + mestranol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05012319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05012319.